相关实验视频
Updated: Jul 3, 2025

13:33
Infinium Assay for Large-scale SNP Genotyping Applications
Published on: November 19, 2013
39.0K
全基因组基因型阵列的药物基因组学等位基因覆盖范围:比较分析
Courtney Lenz1, Ankita Narang2, Chad A Bousman2,3,4,5,6,7
1Cumming School of Medicine.
Pharmacogenetics and genomics
|February 15, 2024
概括
为药物基因组学 (PGx) 选择正确的全基因组基因型阵列至关重要. Infinium GDA-PGx阵列提供了最高的PGx等位基因覆盖率,但没有一个阵列在所有应用中都优越.
科学领域:
- 基因组学就是基因组学.
- 药物基因组学 药物基因组学
- 临床遗传学 临床遗传学
背景情况:
- 全基因组基因造型阵列在药物基因组学 (PGx) 研究和临床实践中越来越多地使用.
- 对于PGx应用程序的最佳阵列选择仍然不清楚,需要进行比较分析.
研究的目的:
- 在各种全基因组基因型阵列上对药物基因组学 (PGx) 等位基因进行比较覆盖分析.
- 根据基因覆盖范围,评估阵列适合PGx研究和临床实施,特别是对具有处方指南的基因.
主要方法:
- 分析了七个全基因组数组的基因组表现文件,以覆盖19个药物基因中的523个星基因.
- 特别注意的是分子病理学协会对关键药物基因的Tier 1和Tier 2等位基因组.
主要成果:
- 在评估的数组中,药物基因组异位基因覆盖率有显著差异.
- 在Infinium GDA-PGx阵列中,总体PGx等位基因覆盖率最高 (88%),其次是Axiom PangenomiX Plus (77%),Axiom PangenomiX (72%) 和Axiom PMDA Plus (70%).
- 三个数组 (Infinium GDA-PGx,Axiom PangenomiX Plus,Axiom PMDA Plus) 完全覆盖了Tier 1等位基因,而Axiom PangenomiX则完全覆盖了Tier 2等位基因.
结论:
- 没有单一的全基因组基因型阵列可以为所有药物基因组学 (PGx) 应用提供更好的覆盖范围.
- 对于PGx的阵列选择应考虑特定的基因和等位基因要求.
- 需要进行进一步的研究,比较这些数组中的基因型数据,以验证覆盖率估计.
更多相关视频
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.1K
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
13.0K
相关概念视频
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
DNA Microarrays
17.4K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
17.4K
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K